{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:41:32Z","timestamp":1790188892938,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100724"],"award-info":[{"award-number":["32100724"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672280"],"award-info":[{"award-number":["81672280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971466"],"award-info":[{"award-number":["81971466"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["3332021074"],"award-info":[{"award-number":["3332021074"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.imlet.2022.04.003","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T01:49:25Z","timestamp":1649814565000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Elevated CD38 expression characterizes impaired CD8+ T cell immune response in metastatic pleural effusions"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5540-4959","authenticated-orcid":false,"given":"Yaoxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-7718","authenticated-orcid":false,"given":"Lianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9583-7991","authenticated-orcid":false,"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.imlet.2022.04.003_bib0001","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/crj.13005","article-title":"Novel insights into the systemic treatment of lung cancer malignant pleural effusion","volume":"13","author":"Tissot","year":"2019","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.imlet.2022.04.003_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.597959","article-title":"CD38: an immunomodulatory molecule in inflammation and autoimmunity","volume":"11","author":"Piedra-Quintero","year":"2020","journal-title":"Front. Immunol."},{"issue":"34","key":"10.1016\/j.imlet.2022.04.003_bib0003","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.2217\/fon-2020-0401","article-title":"CD38 as an immunomodulator in cancer","volume":"16","author":"Li","year":"2020","journal-title":"Future Oncol."},{"issue":"11","key":"10.1016\/j.imlet.2022.04.003_bib0004","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s42255-020-00298-z","article-title":"CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD(+) and NMN levels","volume":"2","author":"Chini","year":"2020","journal-title":"Nat. Metab."},{"issue":"9","key":"10.1016\/j.imlet.2022.04.003_bib0005","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/2159-8290.CD-17-1033","article-title":"CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1\/PD-L1 blockade","volume":"8","author":"Chen","year":"2018","journal-title":"Cancer Discov."},{"issue":"19","key":"10.1016\/j.imlet.2022.04.003_bib0006","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1158\/0008-5472.CAN-14-3639","article-title":"CD38-expressing myeloid-derived suppressor cells promote tumor growth in a murine model of esophageal cancer","volume":"75","author":"Karakasheva","year":"2015","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.imlet.2022.04.003_bib0007","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1158\/1078-0432.CCR-18-2752","article-title":"Targeting multiple myeloma with AMG 424, a novel anti-CD38\/CD3 bispecific T-cell-recruiting antibody optimized for cytotoxicity and cytokine release","volume":"25","author":"Zuch de Zafra","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.imlet.2022.04.003_bib0008","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood-2015-12-687749","article-title":"Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma","volume":"128","author":"Krejcik","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.imlet.2022.04.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97022","article-title":"CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients","volume":"3","author":"Karakasheva","year":"2018","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.imlet.2022.04.003_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jgg.2019.06.007","article-title":"Blocking CD38-driven fratricide among T cells enables effective antitumor activity by CD38-specific chimeric antigen receptor T cells","volume":"46","author":"Gao","year":"2019","journal-title":"J. Genet Genomics"},{"issue":"1","key":"10.1016\/j.imlet.2022.04.003_bib0011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmet.2017.10.006","article-title":"CD38-NAD(+)axis regulates immunotherapeutic anti-tumor T cell response","volume":"27","author":"Chatterjee","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.imlet.2022.04.003_bib0012","article-title":"Pepaxto: a New peptide-drug conjugate for heavily pretreated relapsed and refractory multiple myeloma","author":"Jessee","year":"2021","journal-title":"Ann. Pharmacother."},{"issue":"7","key":"10.1016\/j.imlet.2022.04.003_bib0013","volume":"9","author":"Kar","year":"2020","journal-title":"CD38: T Cell Immuno-Metabolic Modulator, Cells"},{"key":"10.1016\/j.imlet.2022.04.003_bib0014","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3389\/fimmu.2019.01187","article-title":"The multi-faceted ecto-enzyme CD38: roles in immunomodulation, cancer, aging, and metabolic diseases","volume":"10","author":"Hogan","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2022.04.003_bib0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1152\/physrev.00035.2007","article-title":"Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology","volume":"88","author":"Malavasi","year":"2008","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.imlet.2022.04.003_bib0016","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/eji.201040726","article-title":"CD38 identifies a hypo-proliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigms","volume":"41","author":"Scalzo-Inguanti","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2022.04.003_bib0017","doi-asserted-by":"crossref","first-page":"C297","DOI":"10.1152\/ajpcell.00139.2017","article-title":"Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion, American journal of physiology","volume":"314","author":"Boslett","year":"2018","journal-title":"Cell Physiol."},{"issue":"4","key":"10.1016\/j.imlet.2022.04.003_bib0018","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1152\/physrev.00046.2020","article-title":"CD38 in the age of COVID-19: a medical perspective","volume":"101","author":"Horenstein","year":"2021","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.imlet.2022.04.003_bib0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2017-06-740944","article-title":"CD38 antibodies in multiple myeloma: back to the future","volume":"131","author":"van de Donk","year":"2018","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.imlet.2022.04.003_bib0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","article-title":"Turning cold into hot: firing up the tumor microenvironment","volume":"6","author":"Duan","year":"2020","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.imlet.2022.04.003_bib0021","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/08820139.2019.1566356","article-title":"Prognostic values of CD38(+)CD101(+)PD1(+)CD8(+) T cells in pancreatic cancer","volume":"48","author":"Zhang","year":"2019","journal-title":"Immunol. Invest."},{"issue":"9","key":"10.1016\/j.imlet.2022.04.003_bib0022","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41590-019-0441-y","article-title":"PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1(+)CD38(hi) cells and anti-PD-1 resistance","volume":"20","author":"Verma","year":"2019","journal-title":"Nat. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.imlet.2022.04.003_bib0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2119\/molmed.2009.00146","article-title":"CD38\/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells","volume":"16","author":"Deaglio","year":"2010","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.imlet.2022.04.003_bib0024","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2022.04.003_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial dynamics controls T Cell fate through metabolic programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.imlet.2022.04.003_bib0026","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nrm3013","article-title":"Mitochondrial fusion and fission in cell life and death","volume":"11","author":"Westermann","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.imlet.2022.04.003_bib0027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molmed.2017.11.005","article-title":"Metabolic control of CD8(+) T cell fate decisions and antitumor immunity","volume":"24","author":"Zhang","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.imlet.2022.04.003_bib0028","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3389\/fimmu.2020.01834","article-title":"Rewiring mitochondrial metabolism for CD8(+) T cell memory formation and effective cancer immunotherapy","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2022.04.003_bib0029","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41423-020-0365-3","article-title":"Enforced PGC-1alpha expression promotes CD8 T cell fitness, memory formation and antitumor immunity","volume":"18","author":"Dumauthioz","year":"2021","journal-title":"Cell Mol. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2022.04.003_bib0030","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","article-title":"Disturbed mitochondrial dynamics in CD8(+) TILs reinforce T cell exhaustion","volume":"21","author":"Yu","year":"2020","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2022.04.003_bib0031","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.imlet.2022.04.003_bib0032","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","article-title":"CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism","volume":"23","author":"Camacho-Pereira","year":"2016","journal-title":"Cell Metab."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247822000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247822000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:04:12Z","timestamp":1762250652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247822000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":32,"alternative-id":["S0165247822000529"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2022.04.003","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated CD38 expression characterizes impaired CD8+ T cell immune response in metastatic pleural effusions","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2022.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}